The Cambridge Centre for AI in Medicine is funded by our industry partners, AstraZeneca and GSK.
This funding represents a fantastic opportunity to develop targeted research programmes through co-supervised, world-class PhD students. We are offering five fully funded studentships per year.
Partnering with CCAIM also represents an excellent opportunity to gain first-mover advantage in cutting-edge AI and machine learning.
“We know the best science doesn’t happen in isolation which is why collaboration is essential to the way we work. This new centre combines world class academia with real-world industrial challenges and will help to develop cutting-edge AI to potentially transform the way we discover and develop medicines.”
Jim Weatherall
Vice President, Data Science & AI, R&D, AstraZeneca“The new Cambridge Centre for AI in Medicine will recruit and train the next generation of practitioners at the intersection of AI, industry and academia. The work of this institute will be critical to translating AI methods from theory to practice, so that we can keep improving our therapeutic discovery efforts and so that together we can make a tangible impact on patients, from diagnosis, to treatment and beyond.”
Kim Branson
Senior Vice President, Global Head of AI and Machine Learning, GSK
